Tanvex BioPharma, Inc.
TWSE:6541.TW
62.3 (TWD) • At close November 12, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) TWD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | 2017 Q4 | 2017 Q3 | 2017 Q2 | 2017 Q1 | 2016 Q4 | 2016 Q3 | 2016 Q2 | 2016 Q1 | 2015 Q4 | 2015 Q3 | 2015 Q2 | 2015 Q1 | 2014 Q4 | 2014 Q3 | 2014 Q2 | 2014 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 17.008 | 3.357 | 9.087 | 5.105 | 17.081 | 30.138 | 7.905 | 8.33 | 3.044 | 3.125 | 4.844 | 0.562 | 0 | 0 | 0 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 89.498 | 75.084 | 88.978 | 0.99 | 6.038 | -10.397 | 10.743 | 7.544 | 2.341 | 21.124 | 1.552 | 0.304 | 57.796 | 60.271 | 0 | 0.157 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -72.49 | -71.727 | -79.891 | 4.115 | 11.043 | 40.535 | -2.838 | 0.786 | 0.703 | -17.999 | 3.292 | 0.258 | -57.796 | -60.271 | 0 | 0.143 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| -4.262 | -21.366 | -8.792 | 0.806 | 0.647 | 1.345 | -0.359 | 0.094 | 0.231 | -5.76 | 0.68 | 0.459 | 0 | 0 | 0 | 0.477 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 204.875 | 291.478 | 287.912 | 414.355 | 408.353 | 512.228 | 387.463 | 333.474 | 353.878 | 276.611 | 287.869 | 335.035 | 403.981 | 356.636 | 402.33 | 387.053 | 517.411 | 553.806 | 475.02 | 616.85 | 457.35 | 450.892 | 413.263 | 406.175 | 574.396 | 259.003 | 293.302 | 224.625 | 280.418 | 286.08 | 392.455 | 254.827 | 243.127 | 217.58 | 193.339 | 201.635 | 133.612 | 133.612 | 93.989 | 93.989 | 76.29 | 76.29 |
| General & Administrative Expenses
| 78.504 | 53.508 | 100.21 | 86.521 | 100.031 | 117.53 | 63.146 | 53.017 | 55.484 | 37.107 | 42.708 | 45.169 | 45.985 | 42.922 | 48.6 | 55.723 | 49.62 | 55.1 | 54.221 | 62.633 | 74.505 | 68.207 | 46.692 | 68.913 | 71.495 | 74.83 | 86.605 | 78.18 | 73.357 | 70.06 | 81.236 | 57.193 | 60.423 | 44.677 | 54.114 | 45.626 | 35.008 | 35.008 | 38.578 | 38.578 | 23.592 | 23.592 |
| Selling & Marketing Expenses
| 7.095 | 5.307 | 24.621 | 10.585 | 3.737 | 10.473 | 11.129 | 5.876 | 9.065 | -0.081 | 9.91 | 8.655 | 9.764 | 14.1 | 9.585 | 10.623 | -5.058 | 14.927 | 14.419 | 20.016 | 17.06 | 16.983 | 13.001 | 9.821 | 8.684 | 4.307 | 4.448 | 6.093 | 0 | 0 | 0 | 0 | 0 | 44.677 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 85.599 | 58.812 | 124.827 | 97.106 | 103.768 | 128.003 | 74.275 | 58.893 | 64.549 | 37.026 | 52.618 | 53.824 | 55.749 | 57.022 | 58.185 | 66.346 | 44.562 | 70.027 | 68.64 | 82.649 | 91.565 | 85.19 | 59.693 | 78.734 | 80.179 | 79.137 | 91.053 | 84.273 | 73.357 | 70.06 | 81.236 | 57.193 | 60.423 | 44.677 | 54.114 | 45.626 | 35.008 | 35.008 | 38.578 | 38.578 | 23.592 | 23.592 |
| Other Expenses
| 1.715 | 13.234 | -16.257 | 8.079 | 0.003 | 0.596 | -4.105 | -1.159 | 2.359 | 12.438 | -0.783 | 0.537 | 90.471 | 0.958 | -1.651 | -1.187 | -2.976 | 10.511 | 11.033 | 15.067 | 19.863 | 23.572 | 56.725 | 0.004 | 13.717 | 8.958 | -21.322 | 3.277 | 5.104 | 6.334 | 8.329 | 13.768 | -15.294 | 100.295 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 290.474 | 350.29 | 412.739 | 511.461 | 512.121 | 640.231 | 461.738 | 392.367 | 418.427 | 313.637 | 340.487 | 388.859 | 459.73 | 413.658 | 460.515 | 453.399 | 561.973 | 623.833 | 543.66 | 699.499 | 548.915 | 536.082 | 472.956 | 484.909 | 654.575 | 338.14 | 384.355 | 308.898 | 353.775 | 356.14 | 473.691 | 312.02 | 303.55 | 262.257 | 248.448 | 248.238 | 169.494 | 169.494 | 113.538 | 113.538 | 15.692 | 15.692 |
| Operating Income
| -362.964 | -422.017 | -492.63 | -491.202 | -491.562 | -595.176 | -463.869 | -390.393 | -413.445 | -318.68 | -337.368 | -388.601 | -459.73 | -413.658 | -460.515 | -453.256 | -561.973 | -623.833 | -543.66 | -699.499 | -548.915 | -536.082 | -472.956 | -484.909 | -654.575 | -338.14 | -384.355 | -308.898 | -353.775 | -356.14 | -473.691 | -312.02 | -303.55 | -262.257 | -247.453 | -247.261 | -168.619 | -168.619 | -132.566 | -132.566 | -99.882 | -99.882 |
| Operating Income Ratio
| -21.341 | -125.713 | -54.213 | -96.22 | -28.778 | -19.748 | -58.68 | -46.866 | -135.823 | -101.978 | -69.647 | -691.461 | 0 | 0 | 0 | -1,510.853 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -3.439 | 3.855 | -25.41 | -13.739 | -13.93 | -13.024 | -14.139 | -13.826 | -13.589 | -13.166 | -13.271 | -10.193 | 81.11 | -1.478 | -9.592 | -2.671 | 0.518 | 7.11 | 7.435 | 11.216 | 16.012 | 19.292 | 23.879 | 10.188 | 13.717 | 8.958 | -21.322 | 3.277 | 5.104 | 6.334 | 8.329 | 13.768 | -15.294 | 100.295 | -0.807 | -0.975 | -0.748 | -0.748 | 16.278 | 16.278 | 83.903 | 83.903 |
| Income Before Tax
| -366.403 | -418.162 | -518.04 | -504.941 | -505.492 | -608.2 | -478.008 | -404.219 | -427.034 | -331.846 | -350.639 | -398.794 | -378.62 | -415.136 | -470.107 | -455.927 | -561.455 | -616.723 | -536.225 | -688.283 | -532.903 | -516.79 | -449.077 | -474.721 | -640.858 | -329.182 | -405.677 | -305.621 | -348.671 | -349.806 | -465.362 | -298.252 | -318.844 | -161.962 | -248.26 | -248.236 | -169.367 | -169.367 | -116.288 | -116.288 | -15.979 | -15.979 |
| Income Before Tax Ratio
| -21.543 | -124.564 | -57.009 | -98.911 | -29.594 | -20.181 | -60.469 | -48.526 | -140.287 | -106.191 | -72.386 | -709.598 | 0 | 0 | 0 | -1,519.757 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0.318 | 72.35 | -0.023 | 0.402 | 0.049 | 13.024 | 14.139 | 13.826 | 0.023 | 13.166 | 13.271 | 1.178 | 91.802 | 0.022 | -0.956 | 0.528 | 0.024 | 10.511 | 11.033 | 15.067 | 0.025 | 23.572 | 0 | 0.005 | 0.024 | 0 | 0 | 0 | 0 | 0.025 | 0 | 0 | 0 | 0.026 | 0 | 0 | 0.013 | 0.013 | -84.702 | -84.702 | 0.012 | 0.012 |
| Net Income
| -366.721 | -418.162 | -518.017 | -505.343 | -505.541 | -621.224 | -492.147 | -418.045 | -427.057 | -345.012 | -350.639 | -398.794 | -378.62 | -415.158 | -470.107 | -455.927 | -561.479 | -616.723 | -536.225 | -688.283 | -532.928 | -516.79 | -449.077 | -474.721 | -640.882 | -329.182 | -405.677 | -305.621 | -348.671 | -349.831 | -465.362 | -298.252 | -318.844 | -161.988 | -248.26 | -248.236 | -169.38 | -169.38 | -31.586 | -31.586 | -100.693 | -100.693 |
| Net Income Ratio
| -21.562 | -124.564 | -57.006 | -98.99 | -29.597 | -20.613 | -62.258 | -50.185 | -140.295 | -110.404 | -72.386 | -709.598 | 0 | 0 | 0 | -1,519.757 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -2.31 | -3.12 | -3.83 | -3.74 | -3.85 | -5.23 | -4.06 | -3.56 | -3.63 | -2.94 | -0.99 | -3.6 | -3.64 | -3.99 | -1.72 | -5.17 | -6.37 | -7 | -2.12 | -8.46 | -6.22 | -6.36 | -1.85 | -5.75 | -8.36 | -4.3 | -2 | -4.48 | -5.05 | -5.09 | -2.31 | -4.35 | -4.66 | -2.57 | -7.95 | -4.5 | -3.37 | -3.37 | -0.9 | -0.9 | -3.78 | -3.78 |
| EPS Diluted
| -2.31 | -3.12 | -3.83 | -3.74 | -3.85 | -5.23 | -4.06 | -3.49 | -3.56 | -2.88 | -0.99 | -3.58 | -3.56 | -3.88 | -1.72 | -5.05 | -6.17 | -6.79 | -2.12 | -8.04 | -6.22 | -6.05 | -1.85 | -5.75 | -8.36 | -4.3 | -2 | -4.48 | -5.05 | -5.09 | -2.31 | -4.35 | -4.66 | -2.57 | -7.95 | -4.5 | -3.37 | -3.37 | -0.9 | -0.9 | -3.77 | -3.77 |
| EBITDA
| -290.909 | -349.624 | -408.731 | -409.647 | -409.721 | -517.638 | -393.528 | -313.191 | -345.371 | -252.738 | -271.537 | -327.739 | -310.132 | -343.854 | -400.655 | -399.563 | -505.055 | -559.962 | -478.6 | -629.783 | -475.55 | -458.724 | -436.896 | -448.669 | -618.784 | -303.458 | -350.716 | -276.107 | -320.714 | -322.926 | -442.251 | -282.749 | -274.684 | -234.259 | -225.178 | -230.48 | -156.799 | -156.799 | -122.537 | -122.537 | -91.171 | -91.171 |
| EBITDA Ratio
| -17.104 | -104.148 | -44.98 | -80.244 | -23.987 | -17.176 | -49.782 | -37.598 | -113.46 | -80.876 | -56.056 | -583.165 | 0 | 0 | 0 | -1,331.877 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |